Pharma Group Beats Orphan Drug Discount Rule In 340B Fight
A D.C. federal judge voided a new requirement that drugmakers offer discounts when hospitals in the 340B drug discount program use orphan medications to treat relatively common conditions, saying Friday that...To view the full article, register now.
Already a subscriber? Click here to view full article